Cargando…

Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management

Precision medicine defines the attempt to identify the most effective approaches for specific subsets of patients based on their genetic background, clinical features, and environmental factors. Nonalcoholic fatty liver disease (NAFLD) encompasses the alcohol-like spectrum of liver disorders (steato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lonardo, Amedeo, Arab, Juan Pablo, Arrese, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107169/ https://www.ncbi.nlm.nih.gov/pubmed/33829368 http://dx.doi.org/10.1007/s12325-021-01690-1

Ejemplares similares

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
por: Lonardo, Amedeo, et al.
Publicado: (2019)

Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy
por: Hernández, Alejandra, et al.
Publicado: (2020)

Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
por: Lonardo, Amedeo
Publicado: (2021)

Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?
por: Lonardo, Amedeo
Publicado: (2022)

NAFLD: Is There Anything New under the Sun?
por: Lonardo, Amedeo, et al.
Publicado: (2017)

Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective
por: Díaz, Luis Antonio, et al.
Publicado: (2022)

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
por: Arab, Juan P., et al.
Publicado: (2016)

NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk
por: Ballestri, Stefano, et al.
Publicado: (2017)

Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
por: Lonardo, Amedeo, et al.
Publicado: (2016)

Precision medicine approaches for the management of Ewing sarcoma: current perspectives
por: Rizk, Victoria T, et al.
Publicado: (2019)

Applying precision medicine to the diagnosis and management of endocrine disorders
por: Bidlingmaier, Martin, et al.
Publicado: (2022)

Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)

Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016)

Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine
por: Carrieri, Livianna, et al.
Publicado: (2022)

Translational precision medicine: an industry perspective
por: Hartl, Dominik, et al.
Publicado: (2021)

Precision Medicine Approaches with Metabolomics and Artificial Intelligence
por: Barberis, Elettra, et al.
Publicado: (2022)

Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective
por: Galun, Danijel, et al.
Publicado: (2022)

The Role of Metformin in the Management of NAFLD
por: Mazza, Angela, et al.
Publicado: (2012)

Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
por: Di Mauro, Stefania, et al.
Publicado: (2021)

Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness
por: Seymour, Christopher W., et al.
Publicado: (2017)

Precision Medicine Approach to Cochlear Implantation
por: Kim, Yehree, et al.
Publicado: (2022)

Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
por: Hu, Haiming, et al.
Publicado: (2019)

Precision Medicine in the Diagnosis and Management of Orthopedic Biofilm Infections
por: Baldan, Rossella, et al.
Publicado: (2020)

Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
por: Pearce, Steven G, et al.
Publicado: (2013)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
por: Idalsoaga, Francisco, et al.
Publicado: (2020)

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD
por: Cholankeril, Rosann, et al.
Publicado: (2018)

Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine
por: Udler, Miriam S, et al.
Publicado: (2019)

Using Precision Medicine for the Diagnosis and Treatment of Viral Pneumonia
por: Watkins, Richard R.
Publicado: (2022)

Precision Medicine Approaches to Prevent Gastric Cancer
por: Matsuzaki, Juntaro, et al.
Publicado: (2021)

Transdisciplinary Perspectives on Precision Medicine
por: Myers, Hector F., et al.
Publicado: (2021)

Perspective for Precision Medicine for Tuberculosis
por: Lange, Christoph, et al.
Publicado: (2020)

Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease
por: Strianese, Oriana, et al.
Publicado: (2020)

Management of intracranial melanomas in the era of precision medicine
por: Young, Grace J., et al.
Publicado: (2017)

Precision Medicine Management of Chronic Lymphocytic Leukemia
por: Moia, Riccardo, et al.
Publicado: (2020)

A Precision Medicine Approach to Rhinitis Evaluation and Management
por: Crisci, Carlos D., et al.
Publicado: (2020)

Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches
por: Miserocchi, Giacomo, et al.
Publicado: (2022)

Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis
por: Dumas, Marie-Pier, et al.
Publicado: (2021)

Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine
por: Chanias, Ioannis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kgjgcbm87netk1a09ao1hd1i7t